...Wawasan 2020 or Vision 2020 is a malaysian ideal introduced by the former Prime Minister of Malaysia, Mahathir bin Mohamad during the tabling of the Sixth Malaysia Plan in 1991. The vision calls for the nation to achieve a self-sufficient industrialized nation by the year 2020, encompasses all aspects of life, from economic prosperity, social well-being, educational worldclass, political stability, as well as psychological balance. In order to achieve Vision 2020, Mahathir lamented that the nation required an annual growth of 7% (in real terms) over the thirty-year periods (1990–2020), so that the economy would be eightfold stronger than its 1990 GDP of RM115 billion. This would translate to a GDP of RM920 billion (in 1990 Ringgit terms) in 2020.Wawasan 2020 is also the title of an article by William Greider about globalization in Malaysia.Mahathir had outlined nine strategic challenges that Malaysia must overcome to achieve Vision 2020. The first challenge is establishing a united Malaysian nation made up of one Bangsa Malaysia (Malaysian Race). The second challenge is creating a psychologically liberated, secure and developed Malaysian society. The third challenge is fostering and developing a mature democratic society. The fourth challenge is establishing a fully moral and ethical society. The fifth challenge is establishing a matured liberal and tolerant society. The sixth challenge is establishing a scientific and progressive society. The seventh challenge is establishing...
Words: 280 - Pages: 2
...So, what is Vision 2020? The Vision 2020 was developed to be a long-term goal for the nation, the goal of Malaysia becoming a “fully developed country” by year 2020 (The Mahathir Years, 2009). In other words, by the year 2020, Malaysia can be a united nation, with a confident Malaysian society, infused by strong moral and ethical values, living in a society that is democratic, liberal and tolerant, caring, economically just and equitable, progressive and prosperous, and in full possession of an economy that is competitive, dynamic, robust and resilient (Wawasan 2020, nd). However, the Vision 2020 equires the Malaysian economy to grow at 7.0% per annum. The 9th Malaysia Plan envisages an annual growth of 6.5%, while the Third Industrial Master Plan targets 6.3% growth for the plan period (Gregore Pio Lopez, nd). Also, Malaysia could not be fully developed until Malaysia has finally overcome the nine central strategic challenges that have confronted us from the moment of our birth as an independent nation. According to Wawasan 2020, it is to be said that one of the challenges of achieving Vision 2020 will be establishing establishing a united Malaysian nation with a sense of common and shared destiny. This must be a nation at peace with itself, territorially and ethnically integrated, living in harmony and full and fair partnership, made up of one 'Bangsa Malaysia' with political loyalty and dedication to the nation. For instance, this can be seen in the big gap between Malay...
Words: 265 - Pages: 2
...India’s Bid for Olympics 2020 Hospitality: The Expected attendance to the Olympic event is expect to be around 10 million people worldwide. The major issues concern for delhi hosting the games will be the Chronic power cuts. In order to meet the high energy demands during the games, large scale power production initiatives have to be taken to increase the existing capacity from 7000 Mw to 12000 Mw. In addition to physical preparation, free accommodation for all athletes at the Games Village, as well as free transport and other benefits, such as a free trip to the famed Taj Mahal and a reserved lane for participants on selected highways was provided Resorts & Hotel: There are also many luxary resorts in Delhi which can provide you many extra facilities and comfort and have special packages which one can enjoy. The five star hotel, Hotel Ashok, in New Delhi, has a memorandum of Understanding (MoU) between Indian Olympic Association and India Tourism Development Corporation (ITDC) & was Officially the Games Family Hotel for CWG games ,2010. The Hotel Ashok has more than 500 rooms with 60 executive suites. Even though there many hotels in delhi,there is still a need for more hotels & resorts to accomadate the large no. of people Security: Transport: Indira Gandhi International Airport is modernised, expanded, and upgraded. Costing nearly $1.95 billion ,Terminal 3 has increased airport passenger capacity to more than 37 million passengers a year by 2010. A new runway has...
Words: 391 - Pages: 2
...Rugby vs American Football General purpose: to persuade & gain the audiences interest Specific purpose: to get the audience to want to learn more about rugby, and hopefully pass their interest onto their friends and family Thesis: Rugby is everywhere; understanding just a little about the game would bring a common interest between you and the rest of the world Attention: When will our nation (US) get its head out of their asses and realize we are focused on the wrong things for entertainment? Credibility: Over 20 years experience in American football and 12 years experience in Rugby; I believe I have enough time in to be considered a reliable source Preview: I want to share some comparisons with facts and personal experience Main Body A.) I’ll discuss where the two games derived B.) I’ll talk about the differences between injuries, and which game you’re most likely to get injured C.) Lastly, I’ll break down the game by giving you some statistics on how much actual game time action you observe on average during a single game Benefits: 1.) Rugby is a year round sport 2.) The only equipment needed to play rugby are cleats and a mouth guard 3.) Rugby is played on every continent, and in almost every country Solutions: 1.) Use the internet to watch videos and learn more about the rules 2.) Search for nearby teams and look on the schedule for a nearby game 3.) Rent a movie that contains rugby ( ie., Invictus, Forever Strong) Conclusion Action:...
Words: 319 - Pages: 2
...technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Playing a key role in promoting and sustaining development in the vital field of medicines, Indian Pharma Industry boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world. Growth Scenario in 2010 India's pharmaceutical industry is now the third largest in the world in terms of volume. Its rank is 14th in terms of value. Between September 2008 and September 2009, the total turnover of India's pharmaceuticals industry was US$ 21.04 billion. The domestic market was worth US$ 12.26 billion. This was reported by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. As per a report by IMS Health India, the Indian pharmaceutical market reached US$ 10.04 billion in size in July 2010. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. Know more out this in our article on Indian Pharmaceutical Industry- Future Trends Also check out Pharmaceutical Market Trends 2010 Leading...
Words: 1244 - Pages: 5
...Pharmabiz :: Vision of India as pharma power house in 2020 Page 1 of 3 Search Here Search Home Editorial Services Interview Q&A Chronicle Specials ePharmail Archives Join Pharma | Login Home > Chronicle Specials News + Font Resize - Vision of India as pharma power house in 2020 Nandita Vijay, Bengaluru Thursday, December 15, 2011, 08:00 Hrs [IST] The Indian pharma industry has gained significant global presence in the last few years and has been competing with other major countries on equal terms. Its remarkable growth can be attributed to its ability to rapidly access and adopt new technologies and also to its success in evolving an effective mechanism to strengthen research and development. The industry's advanced manufacturing facilities have earned laurels from global regulatory authorities. As a result, the world today turns to the Indian pharma industry not only for high-quality and low-cost generic drugs, but also for in-licensing and out -licensing of drugs. The robust Indian pharma industry today produces a range of formulations, has the expertise for active pharmaceutical ingredients (APIs) and sees significant opportunities for value-creation. Hence, the theme of the 63rd edition of IPC, ‘Pharma Vision 2020: India: The Pharma Power house’, encapsulates the present stature of the Indian pharma industry. India, the pharma power house India ranks third in terms of manufacturing pharma products by volume and 14th in value terms...
Words: 2709 - Pages: 11
...Pharmaceutical and Medical Products Practice India Pharma 2020 Propelling access and acceptance, realising true potential The report is furnished to the recipient for information purposes only. Each recipient should conduct its own investigation and analysis of any such information contained in this report. No recipient is entitled to rely on the work of McKinsey & Company, Inc. contained in this report for any purpose. McKinsey & Company, Inc. makes no representations or warranties regarding the accuracy or completeness of such information and expressly disclaims any and all liabilities based on such information or on omissions therefrom. The recipient must not reproduce, disclose or distribute the information contained herein without the express prior written consent of McKinsey & Company, Inc. 12 Executive summary India Pharma 2020: Propelling access and acceptance, realising true potential 13 Global pharmaceutical markets are in the midst of major discontinuities. While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. The Indian pharmaceuticals market, along with the markets of China, Brazil and Russia, will spearhead growth within these markets. The Indian pharmaceuticals market has characteristics that make it unique. First, branded generics dominate, making up for 70 to 80 per cent of the retail market. Second, local players have enjoyed a dominant position driven by formulation...
Words: 9542 - Pages: 39
...Analyse sectorielle Secteur de la « Santé / Pharma » 16 Avril 2009 Liminaires • Ce document a pour objet de dresser une analyse prospective de la filière « Santé / Pharma » – ses grands enjeux, ses forces en présence, ses mutations en cours – et de donner à voir des pistes de réflexions / de solutions, en particulier pour les laboratoires pharmaceutiques. • Il est organisé en trois principaux chapitres : • Premier chapitre : diagnostic flash du secteur restitué sous la forme d’une représentation de la • • filière et de ses mutations majeures. Deuxième chapitre : pistes de réflexion / de solution à engager à court ou moyen terme pour répondre aux changements (outre celles d’ores et déjà engagées par les leaders de la filière). Troisième chapitre : analyse détaillée de la filière. • Les abréviations / sigles techniques spécifiques au secteur sont explicités dans un glossaire chapitre 4. 2008 Copyright emoveo sarl. Tous droits réservés 2 Sommaire • 1- Représentation de la filière Santé / Pharma et de ses mutations majeures • Contexte et enjeux majeurs • Tendances de fond et ruptures • Chaîne de valeur et changements induits • Emergence de nouveaux acteurs • 2 - Pistes de réflexions et de solutions • 3 - Analyse détaillée de la filière • Analyse de marché et analyse de l’environnement • Extraits du rapport d’étude « Pharma 2020 : The vision – Which path will you take ? » • Zoom sur les outils CRM Pharma • Fiches d’identité des 15 premiers laboratoires...
Words: 8260 - Pages: 34
...Indian Pharma Industry – an overview April 13, 2012 The demand for pharmaceutical products in India is significant and is driven by low drug penetration, rising middle-class & disposable income, increased government & private spending on healthcare infrastructure, increasing medical insurance penetration etc. The Indian pharmaceutical industry is growing at about 8 to 9 percent annually according to “A Brief Report Pharmaceutical Industry in India,” published in January 2011. The Pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. There are approximately 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). I. Current Scenario: India's pharmaceutical market grew at 15.7 per cent during December 2011. Globally, Indiaranks third in terms of manufacturing pharma products by volume. According to McKinsey, the Pharmaceutical Market is ranked 14th in the world. By 2015 it is expected to reach top 10 in the world beating Brazil, Mexico, South Korea and Turkey. More importantly, the incremental market growth of US$ 14billion over the next decade is likely to be the third largest among all markets. The US and China are expected to add US$ 200bn and US$ 23bn respectively. McKinsey & Company’s report, “India Pharma 2020:...
Words: 1969 - Pages: 8
...1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ................................................................................................................................................. 6 Indian Pharma Industry................................................................................................................................. 7 Drivers of the Demand ........................................................
Words: 7934 - Pages: 32
...pharmaceutical industry is estimated at $8 billion in 2013 and had been growing at an average rate of 8–9 %. The industry was highly fragmented with more than 1000 players out of which 30% of market was controlled by top ten companies and the rest of 70% by small companies. The Global pharmaceutical industry was estimated at $ 600 billion in 2013. Indian pharmaceutical industry has become more innovative and enterprising with more investment in R&D especially since the WTO agreement was signed. Indian drug makers command 10 per cent share in the USD 30 billion US generic drug market and also has the highest (over 150) US Foods & Drug Administration (FDA) approved facilities. US accounts for one-fourth of the Indian drug exports. The share of Indian pharma companies in the total approvals for generic drugs called Abbreviated New Drug Application (ANDA) has risen steadily. From 32 per cent in 2009, it went up to 38.5 per cent in 2013. Increasing share of Indian companies in total ANDAs approved by the USFDA can be attributed to increase spending by them for research and development (R&D) activities. As per CMIE’s database, the industry’s R&D expenses to sales ratio jumped to around five per cent in 2012-13 from around three per cent in 2003-04. The export of drugs from India is expected to grow by 4.2 per cent to USD 15.2 billion in 2013-14. Around USD 16.3 billion of drugs are likely to be shipped from the country in 2014-15. This translates into a growth of 7.3 per cent. In 2015-16, drug...
Words: 11886 - Pages: 48
... * Company Profiles (10 Companies) * Financial Ratio Analysis * DCF Valuation * Valuation Shares 8) Conclusion 74 9) Bibliography 76 RESEARCH OBJECTIVES Research Project Topic: “Analysis and Valuation of the Indian Pharma Sector” The research objectives of this specialization project are: 1) Identifying the key indicators of the Global Pharma Industry 2) Understand and analyze the Indian Pharma Industry and identify the prominent players. 3) To examine the trends in the pharma industry 4) Fundamental and Technical Analyses of the Top 10 pharma companies in India. The main objective of this study is: 1) Valuation of the Top 10 Pharma companies 2) Finding the correct share price of the company 3) Making investment decision of- Buying, Selling or Holding the stocks of the respective pharma company. EXECUTIVE SUMMARY * Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1...
Words: 11741 - Pages: 47
...pharmaceutical sector accounts for about 2.4 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms and is expected to expand at a Compound Annual Growth Rate (CAGR) of 15.92 per cent to US$ 55 billion by 2020 from US$ 20 billion in 2015. With 71 per cent market share, generic drugs form the largest segment of the Indian pharmaceutical sector. By 2016, India is expected to be the third-largest global generic Active Pharmaceutical Ingredient (API) merchant market. The country accounts for the second largest number of Abbreviated New Drug Applications (ANDAs) and is the world’s leader in Drug Master Files (DMFs) applications with the US. Indian drugs are exported to more than 200 countries in the world, with the US as the key market. Generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally and expected to expand even further in coming years. Pharmaceuticals Exports Promotion Council (Pharmexcil) expects pharmaceutical exports to reach US$ 25 billion in 2015. The Government of India plans to set up a US$ 640 million venture capital fund to boost drug discovery and strengthen pharmaceutical infrastructure. The ‘Pharma Vision 2020’ by the government’s Department of Pharmaceuticals aims to make India a major hub for end-to-end drug discovery. Trends in Indian Pharmaceutical sector revenue * The Indian pharmaceuticals market increased at a CAGR of 12.79...
Words: 1727 - Pages: 7
...Pharmaceuticals and Life Sciences Global pharma looks to India: Prospects for growth Table of contents Introduction 03 Background 04 A fast growing economy An expanding pharmaceutical market Government-provided healthcare improving, but private healthcare dominates Domestic market overview 09 Background Consolidation underway, despite challenges Contract manufacturing Vaccines Over the counter market holds significant potential Reaching the untapped rural market Growing Research & Development 15 Overview Clinical trials Biotech and biosimilars on track for growth Other growth areas Bioinformatics 20 Stem cell research Medical devices Global Pharma’s evolving business models and options in India 23 Background Export-oriented business (Contract Research and Manufacturing Services) Licensing Franchising Joint ventures Wholly-owned subsidiaries Practical concerns 27 Infrastructure Tax environment Counterfeiting Intellectual property Conclusion 30 Related reading: Pharma 2020 31 References 32 Acronyms 38 Introduction The pharmaceutical industry’s main markets are under serious pressure. North America, Europe and Japan jointly account for 82% of audited and unaudited drug sales; total sales reached US$773 billion in 2008, according to IMS Health. Annual growth in the European Union (EU) has slowed to 5.8%, and sales are increasing at an even more sluggish rate...
Words: 17333 - Pages: 70
...Industry Snapshot The Indian pharmaceutical industry is highly dynamic and offers great opportunities for both domestic and foreign companies. The industry is estimated to have generated revenue worth US$ 13.1 billion in FY 2011, according to a new Research and Market’s report, “Indian Pharma Sector Forecast 2014.” India will emerge as a leading global player in pharmaceutical industry by 2020, securing a place among the top five major global markets, according to Ikon Marketing Consultant (IMC). Also, Associated Chambers of Commerce and Industry (Assocham) has said it expects the Indian pharmaceutical industry to reach US$ 20 billion by 2015, making it one of the world's top 10 pharmaceuticals markets. India has a strong local manufacturing base and domestic players are developing substantial international presence. Healthcare is also one of the largest service sector industries in India, in terms of revenue and employment. Rising health awareness and increasing government expenditure on healthcare sector is driving growth in the sector. Medical tourism and health insurance are also on a rise, with significant growth in healthcare sector and establishment of large number of hospitals, both public and private. The Indian healthcare industry, estimated at US$ 50 billion, is expected to reach over US$ 75 billion by 2012, and US$ 100 billion by 2015. Talent Challenges While specialised talent is critical for any knowledge industry, it is more so within the pharmaceuticals industry...
Words: 6445 - Pages: 26
